Total raised
—
Stage
Pre-Funding
Founded
2020
Headcount
6
HQ
Herzliya
Sector
Health Tech & Life Sciences
About
TanoMed is developing immune cell-targeted nanodelivery solutions designed to improve therapeutic efficacy by triggering tumor destruction following T- and B-cell priming. TanoMeds precision immuno-oncology therapy is based on a novel dendritic cell-targeted nano-immunomodulator platform that combines antigen-carrying capacity with in vivo targeting and modulation of DC function, thereby expanding the host antitumor specific T-effector phenotype and improving sensitivity and long-term tumor recognition.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B2C
Tags
cancerimmunotherapypharma-companiesoncologynanotechnologygastroenterologybiotechnologycancer-therapypersonalized-medicinestealthmode